Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1995;26:1593-1597

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuda, H.
Right arrow Articles by Kitani, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuda, H.
Right arrow Articles by Kitani, M.

(Stroke. 1995;26:1593-1597.)
© 1995 American Heart Association, Inc.


Articles

Differences Between Treated and Untreated Hypertensive Subjects in the Extent of Periventricular Hyperintensities Observed on Brain MRI

Hitoshi Fukuda, MD Mitsuhiro Kitani, MD

From the Department of Neurology, Masuda Red Cross Hospital, Shimane, Japan.

Correspondence to Hitoshi Fukuda, MD, I-103-1 Otoyoshi, Masuda, Shimane 698, Japan.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowSubjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background and Purpose Several reports have stated that the periventricular abnormalities found on T2-weighted MRI or CT are associated with age and hypertension. However, there have been no reports on the effect of hypertension treatment on white matter abnormalities. We studied the association between cardiovascular risk factors and periventricular hyperintensities (PVHs) on T2-weighted MRI and the differences between treated and untreated hypertensive subjects in the extent of PVHs.

Methods The extent of PVH observed on 238 MRI scans was assessed retrospectively in 238 patients older than 40 years with the use of a five-point (0 to 4) classification scale. Hypertensive subjects were divided into two groups: patients receiving no or irregular treatment and patients receiving regular treatment for hypertension.

Results Age, hypertension, treatment of hypertension, and multiple cerebral vascular lesions on MRI correlated significantly and independently with the extent of PVH. Sex and diabetes mellitus did not correlate with PVH. The Mann-Whitney U test showed significantly more extensive PVH in subjects with no or irregular treatment of hypertension compared with normotensives (2.5±0.7 versus 1.9±0.6, P<.0001) and compared with subjects receiving regular treatment of hypertension (2.5±0.7 versus 2.1±0.5, P=.0019). The latter patients had more extensive PVH than normotensives, but the difference was not significant. Mean systolic and diastolic blood pressure differed significantly among the three groups.

Conclusions Hypertension and age were major predictors of the extent of PVH. Regular treatment for hypertension appeared to prevent the progression of PVH.


Key Words: drug therapy • hypertension • magnetic resonance imaging • white matter


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowSubjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Several reports have described PVHs and other hyperintensities of the deep white matter detected on T2-weighted MRI or PVLs on x-ray CT scans of the head. Since several reports1 2 3 4 5 6 7 8 9 10 suggested that such findings are associated with cognitive decline, their prevention would seem important. Age1 2 3 11 12 13 14 15 16 17 18 19 and hypertension2 3 4 5 6 7 11 12 13 14 15 16 17 20 21 are reportedly major predictors of PVH or PVL. While one can infer that treatment of hypertension can prevent the progression of white matter hyperintensities, there are no such reports. Accordingly, we studied the association between cardiovascular risk factors and PVHs and the differences between treated and untreated hypertensive subjects in the extent of PVHs in a retrospective evaluation.


*    Subjects and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Subjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Subjects
We reviewed the clinical records of 939 patients who visited the Department of Neurology and underwent MRI scans of the head (1083 consecutive brain MRI scans) between 1991 and 1994. From the 939 patients, we selected 238 patients who fulfilled the following conditions: (1) age older than 40 years; (2) complete clinical and laboratory data including urinalysis, complete blood count, fasting plasma glucose, HbA1c, and blood chemistry tests for liver and kidney function in the fasting state; (3) details on hypertension treatment available; (4) 75-g oral glucose tolerance test performed when DM was suspected; (5) no history of multiple sclerosis, cerebral tumor, or leukodystrophy; and (6) MRI without artifacts and of quality sufficient for evaluating PVH grade. Most patients were excluded from this study because of incomplete laboratory findings. The group consisted of 106 men and 132 women (age range, 41 to 91 years; mean, 66.7 years). Diagnoses were cerebral infarction (108), transient ischemic attack (13), Parkinson's disease (13), epilepsy (9), cerebral bleeding (5), and others (90) such as neurosis, depression, headache, numbness, and dizziness. The number of diabetic patients and hypertensives is shown in Tables 1Down and 2Down.


View this table:
[in this window]
[in a new window]
 
Table 1. Relative Frequency of Various Factors in Each PVH Grade (0-4)


View this table:
[in this window]
[in a new window]
 
Table 2. Univariate Correlations Between Clinical Parameters and PVH Grade

Methods
Arterial blood pressure was measured with the patient seated. If a patient had received medical treatment, the blood pressure recorded was that measured during treatment. In most cases we used the blood pressure data obtained on the day of MRI examination. When the MRI had been performed only in the acute stage of stroke, we used in our analysis the blood pressure measured at the chronic stage more than 1 month after stroke onset.

Hypertension was considered present if the patient's blood pressure was 160/95 mm Hg or higher in any visit or if the patient had received medical treatment for hypertension.

Conditions of treatment for hypertension were defined as follows. If a hypertensive patient had not received medical treatment or had a history of discontinuing medical treatment, that subject was classified as receiving no or irregular treatment. If a hypertensive patient regularly continued taking medical treatment since the hypertension had been diagnosed, he was classified as receiving regular treatment.

MRI studies were performed on a 1.0-T superconductive scanner (Shimadzu SMT100X). Spin-echo pulse sequences were used to generate both T1-weighted (TR, 400 ms; TE, 15 ms; NEX, 3; or TR, 500 ms; TE, 20 ms; NEX, 3) and T2-weighted (TR, 3000 ms; TE, 90 ms; NEX, 1) axial brain images. Matrix was 256x256; scanning was done in the orbitomeatal plane with multipolarization radiofrequency head coil; these sections were 8 mm thick and separated by a 2-mm interscan gap; they began at the medullocervical cord junction and extended superiorly to the inner table of the skull.

Definition of Vascular Lesions on MRI
We counted two types of lesions. One type showed hyperintensity on T2-weighted imaging and obvious low intensity on T1-weighted imaging; its diameter exceeded 3 mm. We planned to include cerebral infarction on MRI, but a large état criblé can be included in such a lesion.22 23 The other type of lesion showed a low or high intensity, circumscribed by low intensity on T2-weighted imaging. We considered this lesion as intracranial hemorrhage in the chronic stage.24 Vascular lesions were classified as absent, solitary, or multiple according to a total count of these lesions.

Method of Grading PVH on MRI
We excluded from analysis punctate hyperintensities in the deep white matter. Images were read by one of the authors (H.F.) without knowledge of the clinical data. All MRI sections of each subject were used to evaluate PVH grade. We used a newly developed five-point scale to classify PVH (FigureDown): 0, absent; 1, caps only on anterior horns of the lateral ventricle at the level of the basal ganglia; 2, thin lining, smooth halo, or irregular PVH within an inner half area of the white matter at the level of the body of the lateral ventricle; 3, PVH extending into the outer half area of the white matter at any region around the lateral ventricle; and 4, PVH covering the entire white matter. An MRI study that gave borderline results between two grades was automatically assigned to the lower grade. To dichotomize the PVH score for use in logistic regression analysis, PVH was defined as mild if the score was <=2 and as severe if the score was >=3.



View larger version (90K):
[in this window]
[in a new window]
 
Figure 1. Classification of PVH on T2-weighted MRI. Number indicates grade of PVH.

We studied 238 MRI scans of 238 patients, that is, one MRI scan per patient. Of the 238 patients included in the study, 51 patients underwent more than one MRI scan. When a patient had serial scans, the MRI scan done on the same day as the laboratory examinations or the day closest to the examinations was included in the study.

We determined the interrater reliability of the two raters (H.F. and M.K.) using 35 MRI head scans selected to represent the entire range of PVH grades in the study population. Spearman's rank correlation was 0.921 (P<.0001).

Statistical Analysis
Data are reported as mean±SD. One-way ANOVA was used to compare means of ages and blood pressures among three groups. The Mann-Whitney U test was used to test for significant differences in PVH grade between two groups, and the Kruskal-Wallis rank test was used to test for significant differences in PVH grade among three groups. The {chi}2 test was applied to evaluate significant differences between frequency distributions. Spearman's rank correlation was used to make univariate comparisons of PVH grade with age and blood pressures. Multivariate linear regression analysis was used to estimate the independent effects of the predictor variables on the PVH grade. We also performed logistic regression analysis with the PVH score dichotomized and coded as severe (1) or mild (0). A level of P<.05 was accepted as statistically significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Table 1Up shows data on sex, age, hypertension, treatment of hypertension, impaired glucose tolerance, DM, and vascular lesions on MRI in each of the PVH grades. Spearman's rank correlation between age and the PVH grades, systolic blood pressure and the PVH grades, and diastolic blood pressure and the PVH grades was 0.42 (P<.0001), 0.17 (P=.0106), and 0.23 (P=.0004), respectively. All 5 subjects without PVH were normotensive. All 7 subjects with the most severe grade of PVH (grade 4), which covered the entire white matter, were hypertensive. The relative frequency of hypertensive subjects receiving no or irregular treatment for hypertension increased with PVH grade. Of the 7 subjects with PVH grade 4, 6 patients had received no or irregular treatment. Of these 7 patients, 6 patients had multiple lacunar infarcts, 5 patients were demented, and 4 patients had parkinsonism. Five patients receiving no or irregular treatment for hypertension had clinical signs resembling those of subcortical arteriosclerotic encephalopathy (Binswanger's disease).2 25 Vascular lesions on MRI were significantly associated with PVH grade (Table 2Up). The Mann-Whitney U test showed significantly more extensive PVH in the group with multiple MRI lesions versus the group with either no lesion (P<.0001) or a solitary lesion (P<.0001). There was no significant difference in PVH between the group with no lesion versus a solitary lesion (P=.8182). The hypertensives showed more severe PVH scores than the normotensives. Sex or DM was not associated with PVH scores.

Differences in PVH grade and clinical parameters in various conditions of treatment for hypertension are shown in Table 3Down. The Mann-Whitney U test showed a significantly more extensive PVH in the hypertensives receiving no or irregular treatment than either the normotensives (P<.0001) or the hypertensives receiving regular treatment (P=.0019). The hypertensives receiving regular treatment had a more extensive PVH than the normotensives, but the difference was not significant (P=.0545).


View this table:
[in this window]
[in a new window]
 
Table 3. Differences of PVH Grade and Clinical Parameters in Various Conditions of Treatment for Hypertension

The mean systolic or diastolic blood pressure differed significantly among the three groups; it was highest in the hypertensives receiving no or irregular treatment, lower in hypertensives receiving regular treatment, and lowest in the normotensives.

Vascular lesions on MRI were significantly associated with the conditions of treatment for hypertension (P=.0046).

The relative contributions of age (range, 41 to 91 years), sex (female [0], male [1]), hypertension (absent [0], present [1]), treatment of hypertension (no or irregular [0], regular [1]), DM (absent [0], impaired glucose tolerance [1], present [2]), and vascular lesions on MRI (absent [0], solitary [1], multiple [2]) to the PVH score (0 to 4) were assessed by multivariate linear regression analysis. Age, hypertension, treatment of hypertension, and vascular lesions on MRI significantly and independently correlated with PVH. The standardized coefficients were 0.30 (P<.0001), 0.33 (P<.0001), -0.24 (P=.0010), and 0.19 (P=.0036) for these four variables, respectively. Neither sex (P=.3787) nor DM (P=.8556) correlated with PVH scores. The relative contributions of these variables to the PVH score, which was dichotomized and coded as severe (1) or mild (0), were assessed by logistic regression analysis. Age, hypertension, treatment of hypertension, and vascular lesions on MRI significantly and independently correlated with the dichotomized PVH. The r statistics were .23 (P=.0001), .24 (P<.0001), -.17 (P=.0020), and .17 (P=.0018) for these four variables, respectively. Sex (P=.8718) and DM (P=.5721) did not correlate with the dichotomized PVH scores. These results agreed with those of multivariate linear regression analysis.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
up arrowResults
*Discussion
down arrowReferences
 
Previous reports have suggested that PVH or PVL is associated with age,1 2 3 11 12 13 14 15 16 17 18 19 hypertension,2 3 4 5 6 7 11 12 13 14 15 16 17 20 21 DM,16 17 18 a history of stroke,12 15 17 19 21 and a history of heart disease.13 Although age has consistently been the most powerful predictor of PVH or PVL, the association of other factors such as hypertension, DM, a history of stroke, or a history of heart disease with PVH or PVL remains controversial. Most reports2 3 4 5 6 7 11 12 13 14 15 16 17 20 21 have suggested a significant association of hypertension with PVH or PVL, but some1 8 18 19 have failed to establish an independent association of hypertension with PVH or PVL. Our study showed that hypertension is significantly associated with PVH, with an association as strong as that of age in multivariate analysis. In previous neuropathological studies,2 5 23 26 27 28 29 30 periventricular or focal lesions in white matter were attributed to dilated perivascular spaces, lacunar infarcts, demyelinations, or gliosis. Van Swieten et al27 suggested that arteriolosclerosis is the primary factor in the pathogenesis of diffuse white matter lesions in the elderly. Since arteriolosclerosis has been found with increasing age and hypertension,31 32 the lack of any association of hypertension with PVH or PVL is surprising. This inconsistency in results may originate from differences in the conditions of treatment for hypertension among study populations. Our study showed that the difference in PVH grades between hypertensives receiving regular treatment and normotensives was not significant. When most hypertensive subjects in a study receive regular treatment, the association of hypertension with PVH may not be significant.

Vascular lesions on MRI were significantly associated with PVH in our study. Multiple MRI lesions probably show the progressive state of arteriosclerosis. PVH is, therefore, closely connected with cerebrovascular risk factors. Since DM is an important cerebrovascular risk factor, it is probably associated with PVH or PVL. However, our study failed to establish a significant association between PVH and DM. Some studies16 17 18 have suggested an association between DM and PVH or PVL, while others1 3 7 8 12 15 19 21 33 have not. Several possibilities could explain these conflicting results. First, DM is probably a weaker predictor of PVH than hypertension. Several studies on the association of DM with silent infarction have also given conflicting results.34 35 36 37 Reed et al38 reported that serum glucose is marginally associated with atherosclerosis in the large arteries of the circle of Willis, but it is not associated with that in the small arteries; diastolic blood pressure is the only variable that is consistently associated with both atherosclerosis in the large and small arteries and clinical stroke. Second, there may be differences in DM severity and duration among study populations. Third, the number of patients having abnormal glucose metabolism may have been too small in some studies to assess the association of DM with PVH or PVL, since DM is apparently a weak predictor of PVH or PVL. The number was 156 in the study by Manolio et al15 and 142 in the study by Jorgensen et al33 but was less than 38 in other studies.1 3 7 8 12 16 17 18 19 21

Our main purpose was to study differences in the extent of PVH among hypertensives receiving no or irregular treatment or regular treatment for hypertension. Our study showed significantly more extensive PVH in hypertensives receiving no or irregular treatment than in those receiving regular treatment. Of 7 patients with extensive PVH covering the entire white matter, 6 had received no or irregular treatment. Five of the 6 had clinical signs resembling those of subcortical arteriosclerotic encephalopathy (Binswanger's disease).2 25 Although the association of white matter hyperintensities with cognitive decline and other neurological deficits remains controversial,1 2 3 4 5 6 7 8 9 10 11 20 39 40 41 42 when the lesions cover the entire white matter, cognitive decline and other neurological deficits become obvious.2 6 9 43 The fact that normotensives did not show PVH covering the entire white matter suggested that PVH does not extend to cover the entire white matter in the absence of hypertension. If regular treatment of hypertension prevents the progression of white matter hyperintensity and decreases the possibility of obvious cognitive decline, the regular treatment of hypertension is extremely important. Our study has shown that the difference in the extent of PVH between the hypertensives receiving regular treatment and normotensives is not significant. Although this study is retrospective, these findings suggest that regular treatment of hypertension may prevent the progression of white matter hyperintensity.

Regular treatment of hypertension was defined as regular, continuous medical treatment since the diagnosis of hypertension. Blood pressure need not have been maintained within the normal range. Diastolic and systolic blood pressure differed significantly between patients receiving regular treatment of hypertension and normotensives. The differences in the extent of PVH between the two groups, although not significant, may originate from this difference in blood pressures. This suggests that maintaining the blood pressure of hypertensive patients within the normal range from the time of diagnosis may lessen the difference in the extent of PVH between the two groups.


*    Selected Abbreviations and Acronyms
 
DM = diabetes mellitus
NEX = number of excitations
PVH = periventricular hyperintensity
PVL = periventricular lucency
TE = echo time
TR = repetition time


*    Acknowledgments
 
We are grateful to Makiko Nishiyama of the Department of Neurology for her assistance in laboratory examinations.

Received January 18, 1995; revision received June 1, 1995; accepted June 1, 1995.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
up arrowResults
up arrowDiscussion
*References
 

  1. Sarpel G, Chaudry F, Hindo W. Magnetic resonance imaging of periventricular hyperintensity in a Veterans Administration Hospital population. Arch Neurol. 1987;44:725-728. [Abstract]
  2. Kinkel WR, Jacobs L, Polachini I, Bates V, Heffner RR. Subcortical arteriosclerotic encephalopathy (Binswanger's disease). Arch Neurol. 1985;42:951-959. [Abstract]
  3. van Swieten JC, Geyskes GG, Derix MMA, Peeck BM, Ramos LMP, van Latum JC, van Gijn J. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol. 1991;30:825-830. [Medline] [Order article via Infotrieve]
  4. Fukuda H, Kobayashi S, Okada K, Tsunematsu T. Frontal white matter lesions and dementia in lacunar infarction. Stroke. 1990;21:1143-1149. [Abstract/Free Full Text]
  5. Gupta SR, Naheedy MH, Young JC, Ghobrial M, Rubino FA, Hindo W. Periventricular white matter changes and dementia: clinical, neuropsychological, radiological, and pathological correlation. Arch Neurol. 1988;45:637-641. [Abstract]
  6. McQuinn BA, O'Leary DH. White matter lucencies on computed tomography, subacute arteriosclerotic encephalopathy (Binswanger's disease), and blood pressure. Stroke. 1987;18:900-905. [Abstract/Free Full Text]
  7. Bogousslavsky J, Regli F, Uske A. Leukoencephalopathy in patients with ischemic stroke. Stroke. 1987;18:896-899. [Abstract/Free Full Text]
  8. Brott T, Mouradin M, Uthman B. Dementia, ventricular enlargement, and hypertension associated with periventricular hypodensity by computed tomography. Ann Neurol. 1986;20:129-130.
  9. Boone KB, Miller BL, Lesser IM, Mehringer CM, Hill-Gutierrez E, Goldberg MA, Berman NG. Neuropsychological correlates of white-matter lesions in healthy elderly subjects: a threshold effect. Arch Neurol. 1992;49:549-554. [Abstract]
  10. Breteler MMB, van Amerongen NM, van Swieten JC, Claus JJ, Grobbee DE, van Gijn J, Hofman A, van Harskamp F. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging: the Rotterdam Study. Stroke. 1994;25:1109-1115. [Abstract]
  11. Almkvist O, Wahlund LO, Lundman GA, Basun H, Backman L. White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol. 1992;49:626-632. [Abstract]
  12. Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R. Incidental subcortical lesion identified on magnetic resonance imaging in the elderly, I: correlation with age and cerebrovascular risk factors. Stroke. 1986;17:1084-1089.[Abstract/Free Full Text]
  13. Lindgren A, Roijer A, Rudling O, Norrving B, Larsson EM, Eskilsson J, Wallin L, Olsson B, Johansson BB. Cerebral lesions on magnetic resonance imaging, heart disease and vascular risk factors in subjects without stroke: a population-based study. Stroke. 1994;25:929-934. [Abstract]
  14. Kobayashi S. Asymptomatic cerebral infarction in health screening of the brain. Clin Neurol (Tokyo). 1992;32:1367-1369.
  15. Manolio TA, Kronmal RA, Burke GL, Poirier V, O'Leary DH, Gardin JM, Fried LP, Steinberg EP, Bryan N. Magnetic resonance abnormalities and cardiovascular disease in older adults: the Cardiovascular Health Study. Stroke. 1994;25:318-327. [Abstract]
  16. Kertesz A, Black SE, Tokar G, Benke T, Carr T, Nicholson L. Periventricular and subcortical hyperintensities on magnetic resonance imaging: `rims, caps, and unidentified bright objects.' Arch Neurol. 1988;45:404-408. [Abstract]
  17. Hijdra A, Verbeeten B Jr, Verhulst JAPM. Relation of leukoaraiosis to lesion type in stroke patients. Stroke. 1990;21:890-894. [Abstract/Free Full Text]
  18. Schmidt R, Fazekas F, Kleinert G, Offenbacher H, Gindl K, Payer F, Freidl W, Niederkorn K, Lechner H. Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter: a comparative study between stroke patients and normal volunteers. Arch Neurol. 1992;49:825-827. [Abstract]
  19. Sullivan P, Pary R, Telang F, Rifai AH, Zubenko GS. Risk factors for white matter changes detected by magnetic resonance imaging in the elderly. Stroke. 1990;21:1424-1428. [Abstract/Free Full Text]
  20. Schmidt R, Fazekas F, Offenbacher H, Lytwyn H, Blematl B, Niederkorn K, Horner S, Payer F, Freidl W. Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. Arch Neurol. 1991;48:417-420. [Abstract]
  21. Inzitari D, Diaz F, Fox A, Hachinski VC, Steingart A, Lau C, Donald A, Wade J, Mulic H, Merskey H. Vascular risk factors and leuko-araiosis. Arch Neurol. 1987;44:42-47. [Abstract]
  22. Udaka F. Asymptomatic cerebral infarction. Jpn J Stroke (Tokyo). 1991;13:490-494.
  23. Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepfer WW. Brain MR: pathologic correlation with gross and histopathology, I: lacunar infarction and Virchow-Robin spaces. AJR Am J Roentgenol. 1988;151:551-558. [Abstract/Free Full Text]
  24. Bradley WG. MRI of hemorrhage and iron in the brain. In: Stark DD, Bradley WG, eds. Magnetic Resonance Imaging. St Louis, Mo: CV Mosby Co; 1988:359-374.
  25. Olszewski J. Subcortical arterio-sclerotic encephalopathy: review of the literature on the so-called Binswanger's disease and presentation of two cases. World Neurol. 1962;3:359-375.
  26. Grafton ST, Sumi SM, Stimac GK, Alvord EC, Shaw CM, Nochlin D. Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter. Arch Neurol. 1991;48:293-298. [Abstract]
  27. van Swieten JC, van Den Hout JHW, van Ketel BA, Hijdra A, Wokke JHJ, van Gijn J. Periventricular lesions in the white matter on magnetic-resonance-imaging in the elderly: a morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain. 1991;114:761-774. [Abstract/Free Full Text]
  28. Kirkpatrick JB, Hayman LA. White-matter lesions in MR imaging of clinically healthy brains of elderly subjects: possible pathologic basis. Radiology. 1987;162:509-511. [Abstract/Free Full Text]
  29. Marshall VG, Bradley WG Jr, Marshall CE, Bhoopat T, Rhodes RH. Deep white matter infarction: correlation of MR imaging and histopathologic findings. Radiology. 1988;167:517-522. [Abstract/Free Full Text]
  30. Awad IA, Johnson PC, Spetzler RF, Hodak JA. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly, II: postmortem pathological correlations. Stroke. 1986;17:1090-1097.[Abstract/Free Full Text]
  31. Ross Russel RW. Observations on intracerebral aneurysms. Brain. 1963;86:424-442.
  32. Cook TA, Yates PO. A histometric study of cerebral and renal arteries in normotensives and chronic hypertensives. J Pathol. 1972;108:129-135. [Medline] [Order article via Infotrieve]
  33. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes: the Copenhagen Stroke Study. Stroke. 1994;25:1977-1984. [Abstract]
  34. Kase CS, Wolf PA, Chodosh EH, Zacker HB, Kelly-Hayes M, Kannel WB, D'Agostino RB, Scampini L. Prevalence of silent stroke in patients presenting with initial stroke: the Framingham Study. Stroke. 1989;20:850-852. [Abstract/Free Full Text]
  35. Herderschee D, Hijdra A, Algra A, Koudstaal PJ, Kappelle LJ, van Gijn J. Silent stroke in patients with transient ischemic attack or minor ischemic stroke. Stroke. 1992;23:1220-1224. [Abstract/Free Full Text]
  36. Ricci S, Celani MG, Rosa FL, Righetti E, Duca E, Caputo N. Silent brain infarctions in patients with first-ever stroke: a community-based study in Umbria, Italy. Stroke. 1993;24:647-651. [Abstract/Free Full Text]
  37. Jorgensen HS, Nakayama H, Raaschou HO, Gam J, Olsen TS. Silent infarction in acute stroke patients: prevalence, localization, risk factors, and clinical significance: the Copenhagen Stroke Study. Stroke. 1994;25:97-104. [Abstract]
  38. Reed DM, Resch JA, Hayashi T, MacLean C, Yano K. A prospective study of cerebral artery atherosclerosis. Stroke. 1988;19:820-825. [Abstract/Free Full Text]
  39. Rao SM, Mittenberg W, Bernardin L, Haughton V, Leo GJ. Neuropsychological test findings in subjects with leukoaraiosis. Arch Neurol. 1989;46:40-44. [Abstract]
  40. Mirsen TR, Lee DH, Wong CJ, Diaz JF, Fox AJ, Hachinski VC, Merskey H. Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. Arch Neurol. 1991;48:1015-1021. [Abstract]
  41. Tupler LA, Coffey CE, Logue PE, Djang WT, Fagan SM. Neuropsychological importance of subcortical white matter hyperintensity. Arch Neurol. 1992;49:1248-1252. [Abstract]
  42. Hunt AL, Orrison WW, Yeo RA, Haaland KY, Rhyne RL, Garry PJ, Rosenberg GA. Clinical significance of MRI white matter lesions in the elderly. Neurology. 1989;39:1470-1474. [Abstract/Free Full Text]
  43. Ishii N, Nishihara Y, Imamura T. Why do frontal lobe symptoms predominate in vascular dementia with lacunes? Neurology. 1986;36:340-345.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Diabetes CareHome page
B. van Harten, F.-E. de Leeuw, H. C. Weinstein, P. Scheltens, and G. J. Biessels
Brain Imaging in Patients With Diabetes: A systematic review.
Diabetes Care, November 1, 2006; 29(11): 2539 - 2548.
[Full Text] [PDF]


Home page
DiabetesHome page
R. Schmidt, L. J. Launer, L.-G. Nilsson, A. Pajak, S. Sans, K. Berger, M. M. Breteler, M. de Ridder, C. Dufouil, R. Fuhrer, et al.
Magnetic Resonance Imaging of the Brain in Diabetes: The Cardiovascular Determinants of Dementia (CASCADE) Study
Diabetes, March 1, 2004; 53(3): 687 - 692.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
W. D. Taylor, D. C. Steffens, J. R. MacFall, D. R. McQuoid, M. E. Payne, J. M. Provenzale, and K. R. R. Krishnan
White Matter Hyperintensity Progression and Late-Life Depression Outcomes
Arch Gen Psychiatry, November 1, 2003; 60(11): 1090 - 1096.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
W. D. Taylor, J. R. MacFall, J. M. Provenzale, M. E. Payne, D. R. McQuoid, D. C. Steffens, and K. R. R. Krishnan
Serial MR Imaging of Volumes of Hyperintense White Matter Lesions in Elderly Patients: Correlation with Vascular Risk Factors
Am. J. Roentgenol., August 1, 2003; 181(2): 571 - 576.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Dufouil, A. de Kersaint-Gilly, V. Besancon, C. Levy, E. Auffray, L. Brunnereau, A. Alperovitch, and C. Tzourio
Longitudinal study of blood pressure and white matter hyperintensities: The EVA MRI Cohort
Neurology, April 10, 2001; 56(7): 921 - 926.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. S. van der Knaap, S. Naidu, B. K. Kleinschmidt-DeMasters, W. Kamphorst, and H. C. Weinstein
Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids
Neurology, January 25, 2000; 54(2): 463 - 463.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Adachi, M. Takagi, H. Hoshino, and T. Inafuku
Effect of Extracranial Carotid Artery Stenosis and Other Risk Factors for Stroke on Periventricular Hyperintensity
Stroke, November 1, 1997; 28(11): 2174 - 2179.
[Abstract] [Full Text]


Home page
StrokeHome page
R. Mantyla, T. Erkinjuntti, O. Salonen, H. J. Aronen, T. Peltonen, T. Pohjasvaara, and C.-G. Standertskjold-Nordenstam
Variable Agreement Between Visual Rating Scales for White Matter Hyperintensities on MRI : Comparison of 13 Rating Scales in a Poststroke Cohort
Stroke, August 1, 1997; 28(8): 1614 - 1623.
[Abstract] [Full Text]


Home page
StrokeHome page
T. L. Strassburger, H.-C. Lee, E. M. Daly, J. Szczepanik, J. S. Krasuski, M. J. Mentis, J. A. Salerno, C. DeCarli, M. B. Schapiro, and G. E. Alexander
Interactive Effects of Age and Hypertension on Volumes of Brain Structures
Stroke, July 1, 1997; 28(7): 1410 - 1417.
[Abstract] [Full Text]


Home page
StrokeHome page
N. Watanabe, Y. Imai, K. Nagai, I. Tsuji, H. Satoh, M. Sakuma, H. Sakuma, J. Kato, N. Onodera-Kikuchi, M. Yamada, et al.
Nocturnal Blood Pressure and Silent Cerebrovascular Lesions in Elderly Japanese
Stroke, August 1, 1996; 27(8): 1319 - 1327.
[Abstract] [Full Text]


Home page
StrokeHome page
H. Fukuda and M. Kitani
Cigarette Smoking Is Correlated With the Periventricular Hyperintensity Grade on Brain Magnetic Resonance Imaging
Stroke, April 1, 1996; 27(4): 645 - 649.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuda, H.
Right arrow Articles by Kitani, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuda, H.
Right arrow Articles by Kitani, M.